Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 3365 of 6372
-
Could your pacemaker Check-Up be done from home?
Disease control CompletedWhile remote monitoring (RM) technology is currently available and has permitted surveillance and device assessment from any patient location, the use has been inconsistent in Canada, where only 8500 out of a potential 120 000 patients with cardiac implantable electronic devices …
Sponsor: Ratika Parkash • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New study explores Non-Drug pain relief for veterans
Symptom relief CompletedThe overarching goal of this Pain Management Collaboratory Demonstration project is to test a new Whole Health paradigm for chronic pain care, emphasizing non-pharmacological pain self-management that is hypothesized to reduce pain symptoms and improve overall functioning and qua…
Sponsor: San Francisco Veterans Affairs Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Heart scans may predict chemo and radiation damage in breast cancer patients
Knowledge-focused CompletedTo assess the role of myocardial oedema on CMR (T2 mapping) after radiation therapy and cardiotoxic systemic therapy in predicting the incidence of cardiotoxicity, defined as by consensus guidelines\* (decline of LVEF ≥10% points with a final LVEF \<53%) measured on CMR and ECHO …
Sponsor: Oncology Institute of Southern Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Super-Sized flu shot for tots? study tests higher dose
Prevention Stopped earlyThe primary objective of the study was to compare the clinical efficacy of high-dose quadrivalent influenza vaccine (QIV-HD) to standard-dose quadrivalent influenza vaccine (QIV-SD) in participants 6 months through 35 months of age for the prevention of laboratory-confirmed influ…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Can a lupus drug help when given early?
Disease control Recruiting nowThis two year study will evaluate the effects of giving belimumab (Benlysta) to patients with Early Lupus. Early lupus is a diagnosis of lupus within 2 years. Subjects will be randomized to receive belimumab or placebo during the first year. During the second year, subjects who w…
Phase 4 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Hormone swings linked to suicide risk in women: new study
Knowledge-focused CompletedFemale suicide attempts occur more often in the weeks before and after menses onset, and have been linked to ovarian hormone withdrawal. The proposed project will use a two-week intervention to stabilize hormones in females with recent suicidal thoughts; this paradigm is a safe w…
Phase 4 • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New imaging methods could transform PMR diagnosis
Diagnosis OngoingBackground: Polymyalgia rheumatica (PMR) is characterised by pain of the proximal muscles, general symptoms, and raised inflammatory markers. Treatment with prednisolone has several adverse effects. PMR is an exclusion diagnosis, and methods to diagnose and monitor the disease ar…
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Triple immunotherapy cocktail tested in advanced cancers
Disease control CompletedThis study is a Phase 1, open-label, single institution, dose escalation and dose expansion study to evaluate the efficacy, safety, and tolerability of APX005M in combination with nivolumab and ipilimumab in patients with advanced melanoma and RCC.
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a light box help Parkinson's patients sleep better?
Symptom relief CompletedThis study aims to determine the most effective dose of light therapy to improve sleep in people with Parkinson's Disease. Four groups of participants will receive bright-white or dim-red light therapy at different times throughout the day.
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a common heart drug protect HIV patients from heart failure?
Disease control CompletedPersons with HIV, even those well-treated, are at increased risk for heart disease when compared to the general population. Two hormones called aldosterone and brain natriuretic peptide (BNP), which have been shown to be abnormal in HIV, may be associated with inflammation as wel…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a common bladder drug help boys with rare birth defect?
Disease control Recruiting nowBoys with posterior urethral valves have bladder dysfunction of varying severity. Early treatment of these children with anticholinergics is recommended by some teams, although there have never been any clear studies on the subject. To our knowledge, no comparative study of the e…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Virus and radiation combo takes aim at rare sarcomas
Disease control OngoingThe purpose of this research study is to determine the safety and tolerability of talimogene laherparepvec when combined with radiation therapy. Approximately 46 people will take part in this study conducted by investigators at the University of Iowa.
Phase 1/2 • Sponsor: John Rieth • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Smartphone mood tracking may predict Post-Stroke depression
Knowledge-focused CompletedThe recent development of acute phase treatments has dramatically improved stroke functional outcome but post-stroke neuropsychiatric disorders, notably post-stroke depression, continue to contribute to the heavy burden of stroke. While these conditions affect about 25% of stroke…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Veterans sharpen thinking skills from home in new TBI study
Symptom relief CompletedThis study will use technology to deliver effective treatment for cognitive problems associated with TBI to Veterans at home, which may result in improved daily functioning and increased access to health care for the growing population of aging Veterans with history of TBI. The s…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Dry needling may unlock stiff muscles after stroke
Symptom relief OngoingThe study team is recruiting 20 adults with spasticity due to chronic stroke and 20 adults with no neurological injuries for a 2 day study. In people with chronic stroke, one of the most common and disabling problems is spasticity (increased muscle tone or muscle stiffness). The …
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New app aims to reboot language after stroke
Symptom relief CompletediTALKBetter will provide an app-based therapy for people with word retrieval difficulties who have had a stroke. This study aims to test the therapy application for people with naming difficulties through a small scale item-randomized controlled trial.
Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Promising combo for relapsed leukemia in kids hits early hurdle
Disease control Stopped earlyThe purpose of the phase 1 portion (dose escalation) of the study was to establish an optimally safe and biologically active recommended phase 2 dose (RP2D) and/or to determine maximum tolerated dose (MTD) for gilteritinib in sequential combination with fludarabine, cytarabine an…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Spesolimab shows promise for Long-Term control of painful hand and foot pustules
Disease control Stopped earlyThis study is open to people with palmoplantar pustulosis who took part in previous clinical studies of a medicine called spesolimab. Participants who benefited from spesolimab treatment in the previous studies can join this study. The purpose of this study is to find out how sa…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill aims to slow vision loss in rare usher syndrome
Disease control CompletedThis study will examine the safety and efficacy of NPI-001 Tablets as compared to placebo for 24 months in subjects with vision loss due to RP associated with Usher syndrome.
Phase 1/2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Simple blood draws could spot dementia years early
Knowledge-focused OngoingThis is a biomarker study designed to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) mutations compared to a control group of individuals without known f-FTLD mutations. The NSP is an ancillary study to the …
Sponsor: The Bluefield Project to Cure Frontotemporal Dementia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC